Novartis Social Business (NSB) supports global public health through novel sustainable business models. Our activities are rooted in local communities, where we work with partners to provide affordable, high-quality medicines against infectious and chronic diseases while strengthening healthcare capacity. Everything we do relies on our network of partners, who share our purpose. NSB comprises access-to-medicine legacy programs (Novartis Access, the Novartis Malaria Initiative and Novartis Healthy Family) supported by digital platforms.
2018 report contents
Foreword: Treating patients not diseases: we need a mindset shift (page 3)
About Novartis Social Business (page 4)
Applying learnings from legacy programs and maximizing synergies across activities (page 6)
Changing the pharma model from the few to the many (page 11)
2018 country achievements (page 14)
Driving scientific innovation to address key healthcare needs (page 16)
Embracing digital for better health and stronger healthcare systems (page 20)
Partnering to solve healthcare ecosystem challenges (page 24)
KAF156 antimalarial trial centers are now operational in these countries, and we expect to activate four additional sites by mid-2019.
In February, we signed an agreement with the government’s procurement agency to also distribute Novartis Access medicines in public health facilities. This should allow us to reach an additional 300 000 chronic patients. Later, we signed a distribution agreement with the Catholic Health Service of Cameroon, the country’s largest faith-based organization, which provides health services to more than 30% of the population.
Colombia and El Salvador
In El Salvador, we signed an agreement with the municipality of Santa Tecla to make Novartis Access medicines available to vulnerable populations. We also signed a memorandum of understanding with the Colombian Red Cross to deliver the Novartis Access portfolio to vulnerable populations in the country, starting with Venezuelan refugees.
We entered into a partnership with THET to deliver training and capacity building to bring hypertension, diabetes and chronic respiratory disease services closer to communities. We have also trained 55 pharmacists and health workers from the Red Cross on supply chain and quality assurance.
We engaged in discussions with the government of Ghana and the Sickle Cell Foundation of Ghana to establish a comprehensive and replicable model to help increase access to sickle cell disease medicines and improve patient outcomes.
With information technology provider Tech Mahindra, the Arogya Parivar (Healthy Family) team piloted a digital platform with Aquarelle, a supplier to apparel company Levi’s. Results showed that 16% of factory workers were diagnosed as anemic and subsequently treated. Further, a subgroup analysis showed that absenteeism was reduced by 4% on average in little less than one year. We also ran a pilot to include nutrition supplements in our product offering; unfortunately, we did not manage to bring distribution down to doorstep level in a sustainable manner.
The first Novartis Access medicines are now available in public health facilities via the Kenya Medical Supplies Authority, and other drugs will be added in the coming months. Work is also progressing with MSH and Medtronic Labs to establish an end-to-end system for NCD management.
In September, we signed a distribution and capacity-building agreement with Society for Family Health to launch Novartis Access in six states before rolling out the program across the country. We plan to reach 5 million patients in this first phase.
More than 50 health camps have been conducted with Allied World Healthcare (AWH). Further, the digital platform we have been working on with AWH now has more than 37 000 people profiled. We are currently setting up a pilot to see whether community-based insurance can be offered to these communities, and we are developing a streamlined supply chain model with a leading distributor in the region.
60% of the NSB portfolio is now available in the country and first Novartis Access treatments reached patients this year. In September, with the Ministry of Health and the Rwanda Medical Association, we trained about 200 doctors and initiated capacity-building activities to strengthen local NCD management. We will conduct similar activities through the Rwanda Biomedical Center.
First medicine shipments hit the ground in December. We also started capacity-building activities with the Uganda Heart Institute and with the Uganda Protestant Medical Bureau (UPMB) to provide NCD training to doctors, nurses and healthcare workers. Walimu, a local NGO, will also train public sector officials and the UPMB on the new NCD national treatment guidelines.
Cùng Sống Khỏe (Healthy Family) product sales have grown by more than 50% and health education activities implemented with the Vietnam Cardiology Foundation have reached 10% more people compared to last year. We are currently expanding our activities to the country’s central provinces.
We joined forces with Vodacom Tanzania and the Ministry of Health of Zanzibar to implement SMS for Life in the country. The platform will be deployed to around 190 government-owned health facilities to report weekly medicine stock levels. In September, SMS for Life was awarded the Commonwealth Digital Health Award 2018 in the category emergency informatics.